BioCentury
ARTICLE | Company News

NeoGenesis, Immusol HIV deal

November 6, 2001 8:00 AM UTC

NeoGenesis ( Cambridge, Mass.) and Immusol (San Diego, Calif.) partnered to develop small molecule therapeutics for HIV. Immusol will provide validated HIV cellular targets to be screened by NeoGenesi...